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News from the EuPA Liaison committee: Contributing to shaping 
the HUPO-iMOP initiative (corresponded by Natacha Turck)
The EuPA-HUPO liaison committee works to bridge the 
 interests and efforts of the two international proteome com-
munities, HUPO and EuPA.  While the HUPO organization is 
primarily focused on proteome research related to human 
health and disease, EuPA aims to build a broad, international 
proteome science community where proteome research from 
many overlapping fi elds of life sciences can meet and inter-
act. Therefore, the launch of a new HUPO initiative on Model 
Organism Proteomes (iMOP) in 2011, was greatly welcomed 
by the EuPA organization, and members of the EuPA-HUPO 
liason committee have been key players in the growth and 
progress of the iMOP initiative over the past 3 years. This re-
port aims to provide an update on the developing of the iMOP 
initiative, and to highlight the interactions between EuPA and 
iMOP workgroups. A general introduction to the iMOP initia-
tive was presented earlier by Jones et al., 2012 (The HUPO 
 initiative on Model Organism Proteomes, iMOP. Proteomics. 
2012, Feb;12(3):340-5) .
Aims of the iMOP initiative 
Since its approval in 2011, this young HUPO initiative works 
to provide a broad forum for proteome research which is not 
limited to studies of human samples. 
Integrating proteome studies from a wide variety of species is 
essential, because understanding human health and disease 
strongly relies on understanding the biology of a wide range 
of non-human species. These include proteomes of model 
organisms, pathogens, commensal microbia, and of species 
primarily providing food (farm animals and crops). Compared 
to the human proteome fi eld, proteome research within these 
non-human species is characterized by being run by relatively 
few and small laboratories. Access to technological progress 
and state of the art technologies, remains a major bottleneck 
for scientifi c progress in many species-oriented research labs. 
The iMOP initiative works to bridge across some of these gaps 
in the broader proteome research domain, by promoting ex-
change of knowledge and collaboration across the clinical, 
technology-driven,  and the species-oriented research fi elds. 
At the same time, the iMOP initiative aims to improve access 
and use of a variety of model organisms for human clinical 
research. 
iMOP progress 2011-2013: 
iMOP workshops took place at the last 3 HUPO meetings 
 (Geneva 2011, Boston 2012, Yokohama 2013). Reports from 
these workshops have been presented by the iMOP work-
group, most lately by Tholey et al., 2103 (Model organisms 
proteomics: from holobionts to human nutrition. Proteomics. 
Proteomics. 2013,Sep;13(17):2537-41).
The 4th iMOP workshop was recently held at the 2013 EuPA 
conference in St. Malo, France. This workshop focused on 
highlighting the benefi ts of cross-species proteome research, 
and did successfully reach a very broad range of proteome 
research fi elds. The workshop took place as a full day paral-
lel session, attracting an audience that fl uctuated between 
50-200 attendants. Presentations included work on a wide 
range of novel model organisms, pathogens, plants, and mi-
crobial species. The end of the iMOP day was concluded with 
an open discussion on future iMOP focus. 
Workplans for iMOP 2014-2016: 
Michael Hengartner (University of Zurich) has led the iMOP 
initiative from its start, but wishes to step back after taking 
over as the president for University of Zurich. Emøke Bendixen 
(Aarhus University, Denmark) was elected as the next chair. 
She has been an active member of the iMOP workgroup since 
2011. Her additional roles, as chair of the EuPA-HUPO Liaison 
Committee, as well as her membership in the HUPO board of 
directors, provides her with a  strong opportunity to mediate 
interactions in the cross-roads of human and multi-organism 
proteome research. She is currently working together with 
the iMOP initiative group to renew the group of chair persons. 
The aim is to have an organization structure of iMOP, where 
research communities working with plants, animals, micro-
bia, and bioinformatics are well represented and reached. The 
iMOP initiative will continue to promote diversity in the work 
presented at upcoming HUPO conferences, and will continue 
to highlight the importance of non-human research for scien-
tifi c progress in clinical research.  The next iMOP workshops 
will take place at the upcoming HUPO meeting in Madrid 2014. 
Contributions from all fi elds of proteome research are 
 welcome in the iMOP community. 
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